These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 32547310)

  • 1. N-acetylcysteine Restored Heart Rate Variability and Prevented Serious Adverse Events in Transfusion-dependent Thalassemia Patients: a Double-blind Single Center Randomized Controlled Trial.
    Pattanakuhar S; Phrommintikul A; Tantiworawit A; Srichairattanakool S; Chattipakorn SC; Chattipakorn N
    Int J Med Sci; 2020; 17(9):1147-1155. PubMed ID: 32547310
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased sympathovagal imbalance evaluated by heart rate variability is associated with decreased T2* MRI and left ventricular function in transfusion-dependent thalassemia patients.
    Pattanakuhar S; Phrommintikul A; Tantiworawit A; Konginn S; Srichairattanakool S; Chattipakorn SC; Chattipakorn N
    Biosci Rep; 2018 Feb; 38(1):. PubMed ID: 29330222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of three months of treatment with vitamin E and N-acetyl cysteine on the oxidative balance in patients with transfusion-dependent β-thalassemia.
    Haghpanah S; Cohan N; Bordbar M; Bazrafshan A; Karimi M; Zareifar S; Safaei S; Aramesh A; Moghadam M; Fard SAZ; Zekavat OR
    Ann Hematol; 2021 Mar; 100(3):635-644. PubMed ID: 33216196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of N-acetylcysteine on cardiac injury and oxidative stress after abdominal aortic aneurysm repair: a randomized controlled trial.
    Mahmoud KM; Ammar AS
    Acta Anaesthesiol Scand; 2011 Sep; 55(8):1015-21. PubMed ID: 22092168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypertrophy Regression With N-Acetylcysteine in Hypertrophic Cardiomyopathy (HALT-HCM): A Randomized, Placebo-Controlled, Double-Blind Pilot Study.
    Marian AJ; Tan Y; Li L; Chang J; Syrris P; Hessabi M; Rahbar MH; Willerson JT; Cheong BY; Liu CY; Kleiman NS; Bluemke DA; Nagueh SF
    Circ Res; 2018 Apr; 122(8):1109-1118. PubMed ID: 29540445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. N-Acetylcysteine supplementation reduces oxidative stress and DNA damage in children with β-thalassemia.
    Ozdemir ZC; Koc A; Aycicek A; Kocyigit A
    Hemoglobin; 2014; 38(5):359-64. PubMed ID: 25222041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized controlled trial of
    Todd JJ; Lawal TA; Witherspoon JW; Chrismer IC; Razaqyar MS; Punjabi M; Elliott JS; Tounkara F; Kuo A; Shelton MO; Allen C; Cosgrove MM; Linton M; Michael D; Jain MS; Waite M; Drinkard B; Wakim PG; Dowling JJ; Bönnemann CG; Emile-Backer M; Meilleur KG
    Neurology; 2020 Mar; 94(13):e1434-e1444. PubMed ID: 31941795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PREVALENCE AND RISK FACTORS FOR CARDIAC IRON OVERLOAD AND CARDIOVASCULAR COMPLICATIONS AMONG PATIENTS WITH THALASSEMIA IN NORTHERN THAILAND.
    Tantiworawit A; Tapanya S; Phrommintikul A; Saekho S; Rattarittamrong E; Norasetthada L; Chai-Adisaksopha C; Hantrakool S; Charoenkwan P; Chattipakorn N
    Southeast Asian J Trop Med Public Health; 2016 Nov; 47(6):1335-42. PubMed ID: 29634199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxidative stress in hemodialysis patients receiving intravenous iron therapy and the role of N-acetylcysteine in preventing oxidative stress.
    Swarnalatha G; Ram R; Neela P; Naidu MU; Dakshina Murty KV
    Saudi J Kidney Dis Transpl; 2010 Sep; 21(5):852-8. PubMed ID: 20814119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Can N-acetylcysteine reduce red blood cell transfusion burden in patients with transfusion-dependent β-thalassemia?
    Bahoush G; Rahab M; Ahmadvand P
    Pediatr Hematol Oncol; 2024 May; 41(4):251-259. PubMed ID: 38088332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heart Rate Variability for Early Detection of Cardiac Iron Deposition in Patients with Transfusion-Dependent Thalassemia.
    Silvilairat S; Charoenkwan P; Saekho S; Tantiworawit A; Phrommintikul A; Srichairatanakool S; Chattipakorn N
    PLoS One; 2016; 11(10):e0164300. PubMed ID: 27737009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. N-acetylcysteine improves oxidative stress and inflammatory response in patients with community acquired pneumonia: A randomized controlled trial.
    Zhang Q; Ju Y; Ma Y; Wang T
    Medicine (Baltimore); 2018 Nov; 97(45):e13087. PubMed ID: 30407312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of carni Q-gel (ubiquinol and carnitine) on cytokines in patients with heart failure in the Tishcon study.
    Kumar A; Singh RB; Saxena M; Niaz MA; Josh SR; Chattopadhyay P; Mechirova V; Pella D; Fedacko J
    Acta Cardiol; 2007 Aug; 62(4):349-54. PubMed ID: 17824295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imbalance of erythropoiesis and iron metabolism in patients with thalassemia.
    Huang Y; Lei Y; Liu R; Liu J; Yang G; Xiang Z; Liang Y; Lai Y
    Int J Med Sci; 2019; 16(2):302-310. PubMed ID: 30745811
    [No Abstract]   [Full Text] [Related]  

  • 15. Systematic Literature Review of the Burden of Disease and Treatment for Transfusion-dependent β-Thalassemia.
    Betts M; Flight PA; Paramore LC; Tian L; Milenković D; Sheth S
    Clin Ther; 2020 Feb; 42(2):322-337.e2. PubMed ID: 31882227
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progression of liver fibrosis can be controlled by adequate chelation in transfusion-dependent thalassemia (TDT).
    Maira D; Cassinerio E; Marcon A; Mancarella M; Fraquelli M; Pedrotti P; Cappellini MD
    Ann Hematol; 2017 Nov; 96(11):1931-1936. PubMed ID: 28875336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Major Depression in Children with Transfusion-Dependent Thalassemia Is Strongly Associated with the Combined Effects of Blood Transfusion Rate, Iron Overload, and Increased Pro-inflammatory Cytokines.
    Al-Hakeim HK; Najm AH; Al-Dujaili AH; Maes M
    Neurotox Res; 2020 Jun; 38(1):228-241. PubMed ID: 32335809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence and Risk Factors for Cardiac and Liver Iron Overload in Adults with Thalassemia in Malaysia.
    Ngim CF; Lee MY; Othman N; Lim SM; Ng CS; Ramadas A
    Hemoglobin; 2019 Mar; 43(2):95-100. PubMed ID: 31179787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systemic inflammation and oxidative stress post-lung resection: Effect of pretreatment with N-acetylcysteine.
    Bastin AJ; Davies N; Lim E; Quinlan GJ; Griffiths MJ
    Respirology; 2016 Jan; 21(1):180-7. PubMed ID: 26503312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deferasirox reduces iron overload significantly in nontransfusion-dependent thalassemia: 1-year results from a prospective, randomized, double-blind, placebo-controlled study.
    Taher AT; Porter J; Viprakasit V; Kattamis A; Chuncharunee S; Sutcharitchan P; Siritanaratkul N; Galanello R; Karakas Z; Lawniczek T; Ros J; Zhang Y; Habr D; Cappellini MD
    Blood; 2012 Aug; 120(5):970-7. PubMed ID: 22589472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.